Intellia Therapeutics (NTLA) Debt to Equity Ratio: 0.3754

Intellia Therapeutics, Inc. (NTLA)

10.55 -0.86 (-7.54%) USD | NASDAQ | Nov 12, 16:00

10.79 +0.24 (+2.27%) After-Hours: 06:22

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Start Trial.

Date	Value
September 30, 2026	0.3754
June 30, 2026	0.1009
March 31, 2026	0.1296
December 31, 2025	0.139
September 30, 2025	0.1309
June 30, 2025	0.1434
March 31, 2025	0.1529
December 31, 2024	0.2411
September 30, 2024	0.1056
June 30, 2024	0.1095
March 31, 2024	0.107
December 31, 2023	0.1098
September 30, 2023	0.1141
June 30, 2023	0.1107
March 31, 2023	0.1059
December 31, 2022	0.1058
September 30, 2022	0.1184
June 30, 2022	0.079
March 31, 2022	0.0753
December 31, 2021	0.0712
September 30, 2021	0.0686
June 30, 2021	0.1428

Date	Value
March 31, 2021	0.1333
December 31, 2020	0.0746
September 30, 2020	0.0673
June 30, 2020	0.0659
March 31, 2020	0.0983
December 31, 2019	0.0681
September 30, 2019	0.0713
June 30, 2019	0.071
March 31, 2019	0.0738
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	0.00
March 31, 2018	0.00
December 31, 2017	0.00
September 30, 2017	0.00
June 30, 2017	0.00
March 31, 2017	0.00
December 31, 2016	0.00
September 30, 2016	0.00
June 30, 2016	0.00
March 31, 2016	0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks